kynurenic acid has been researched along with 2019 Novel Coronavirus Disease in 5 studies
Kynurenic Acid: A broad-spectrum excitatory amino acid antagonist used as a research tool.
kynurenic acid : A quinolinemonocarboxylic acid that is quinoline-2-carboxylic acid substituted by a hydroxy group at C-4.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 5 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, J | 1 |
| Feng, C | 1 |
| Chen, W | 1 |
| Hou, P | 1 |
| Liu, Z | 1 |
| Zuo, M | 1 |
| Han, Y | 1 |
| Xu, C | 1 |
| Melino, G | 1 |
| Verkhratsky, A | 1 |
| Wang, Y | 1 |
| Shao, C | 1 |
| Shi, Y | 1 |
| Cihan, M | 1 |
| Doğan, Ö | 1 |
| Ceran Serdar, C | 1 |
| Altunçekiç Yıldırım, A | 1 |
| Kurt, C | 1 |
| Serdar, MA | 1 |
| Kucukkarapinar, M | 1 |
| Yay-Pence, A | 1 |
| Yildiz, Y | 1 |
| Buyukkoruk, M | 1 |
| Yaz-Aydin, G | 1 |
| Deveci-Bulut, TS | 1 |
| Gulbahar, O | 1 |
| Senol, E | 1 |
| Candansayar, S | 1 |
| Roberts, I | 1 |
| Wright Muelas, M | 1 |
| Taylor, JM | 1 |
| Davison, AS | 1 |
| Winder, CL | 1 |
| Goodacre, R | 1 |
| Kell, DB | 1 |
| Cai, Y | 1 |
| Kim, DJ | 1 |
| Takahashi, T | 1 |
| Broadhurst, DI | 1 |
| Yan, H | 1 |
| Ma, S | 1 |
| Rattray, NJW | 1 |
| Casanovas-Massana, A | 1 |
| Israelow, B | 1 |
| Klein, J | 1 |
| Lucas, C | 1 |
| Mao, T | 1 |
| Moore, AJ | 1 |
| Muenker, MC | 1 |
| Oh, JE | 1 |
| Silva, J | 1 |
| Wong, P | 1 |
| Ko, AI | 1 |
| Khan, SA | 1 |
| Iwasaki, A | 1 |
| Johnson, CH | 1 |
1 review available for kynurenic acid and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Redressing the interactions between stem cells and immune system in tissue regeneration.
Topics: Animals; Cell Adhesion Molecules; Cell Differentiation; Cell Proliferation; COVID-19; Humans; Immune | 2021 |
4 other studies available for kynurenic acid and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Kynurenine pathway in Coronavirus disease (COVID-19): Potential role in prognosis.
Topics: Adult; Aged; COVID-19; Female; Humans; Kynurenic Acid; Kynurenine; Male; Middle Aged; Picolinic Acid | 2022 |
Psychological outcomes of COVID-19 survivors at sixth months after diagnose: the role of kynurenine pathway metabolites in depression, anxiety, and stress.
Topics: Anxiety; Biomarkers; COVID-19; Depression; Humans; Kynurenic Acid; Kynurenine; Survivors; Tryptophan | 2022 |
Quantitative LC-MS study of compounds found predictive of COVID-19 severity and outcome.
Topics: Chromatography, Liquid; COVID-19; Humans; Kynurenic Acid; Metabolomics; SARS-CoV-2; Tandem Mass Spec | 2023 |
Kynurenic acid may underlie sex-specific immune responses to COVID-19.
Topics: Adult; Aged; Case-Control Studies; COVID-19; Cytokine Release Syndrome; Cytokines; Female; Humans; K | 2021 |